DANIPHARM A/S: Financial statements 2019
CVR: 12335040
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
DANIPHARM A/S (CVR 12335040) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 42,946,302 and a net result of DKK 16,324,503 compared with DKK 10,231,404 the year before. That is an increase of 20.3% compared with the year before. Equity in the 2019 report amounted to DKK 21,157,026. The solvency ratio was 62.3%. The company had 21 employees in the financial year.
- Gross Profit
- DKK 42,946,302
- Profit/Loss
- DKK 16,324,503
- Equity
- DKK 21,157,026
- Total Assets
- DKK 33,982,975
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 42.9 mio. | 16.3 mio. | 21.2 mio. | 21 |
| 2018 | - | 35.7 mio. | 10.2 mio. | 24.8 mio. | 22 |
| 2017 | 93.6 mio. | 37 mio. | 11.3 mio. | 50.6 mio. | 26 |
| 2016 | 85.2 mio. | 40.9 mio. | 15.2 mio. | 41.8 mio. | 22 |
| 2015 | 85.1 mio. | 34.9 mio. | 11.3 mio. | 26.5 mio. | 23 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout DANIPHARM A/S
DANIPHARM A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1988. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Peter Rørvig. The board consists of Niels Ulrik Heine (chair), Helle Rørvig and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 37,586,751 and a net result of DKK 13,717,304 compared with DKK 5,113,647 the year before. Equity in the 2025 report amounted to DKK 60,280,949.